Sandra Kelly, RN, MS, NP, Nurse Practitioner, Brigham & Women’s HospitalAllison Tyler, RN, BSN, OCN®, CCRP, Staff Nurse, Cleveland Clinic
Articles
Immunotherapy: Personalized Treatment for Advanced Prostate Cancer
September 19, 2012
Article
In April 2010, the FDA approved sipuleucel-T for patients with castration-resistant and metastatic prostate cancer, providing a new treatment that would help the body fight its own cancer.